Monte Rosa Therapeutics Inc. reports fourth-quarter and full-year 2025 results Thursday, closing out a year marked by promising clinical data but facing investors’ questions about revenue ...

The S&P/ASX 200 closed 93.6 points higher, up 1.09%.

Investing.com-- Shares of Telix Pharmaceuticals (ASX:TLX) jumped on Tuesday after the company reported positive results from ...

Tommy DeCarlo, a singer who went from posting covers on MySpace to touring as Boston's lead vocalist for years, has died at ...

Monte Rosa Therapeutics recently reported updated Phase 1/2 data showing that its investigational GSPT1 degrader MRT-2359, in combination with enzalutamide, was well-tolerated and produced positive ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

The latest update on Coherus Oncology keeps the model fair value anchored at US$6.75, with no change to the prior price target. Analysts are split on the outlook, with bullish voices arguing that ...

Bayer (XTRA:BAYN) has received preliminary US court approval for a multibillion-dollar class action settlement tied to Monsanto's Roundup weedkiller. The proposed agreement is intended to address tens ...

Bayer has reported a major development within its pharmaceutical pipeline, with new clinical trial data indicating a significant improvement in survival rates for patients with advanced prostate ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time ...